Culture and trust: How Cerevel’s Coles picked Renaud for CEO 

With a series of clinical readouts ahead that could reshape CNS company Cerevel, Tony Coles had been seeking to hand off his CEO role to a trusted biotech veteran who would be a cultural fit. In Ron Renaud, the former CEO of Translate Bio and Idenix who has been a friend of Cole’s for more than a decade, Cerevel believes it has found the right person to lead the company through this transitional chapter.

“It’s not often you get to work with someone closely whom you really like,” Coles told BioCentury. “I’ve always admired Ron’s work ethic and values, and who he is as a leader. His track record speaks for itself.”...